Sign in to view content

Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: One-Year Primary Outcomes From the Randomized RECOVERY Trial

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2019

Charles C. Wykoff, MD, PhD

Diabetic Retinopathy Part I Symposium

Related

Clinical Outcomes of Eyes with Diabetic Macular Edema Switched from Aflibercept to Ranibizumab Therapy
Michael A Klufas, MD
On Demand Cases, Courses, and Papers
2019
EVEREST II Study: Evaluation of Indocyanine Green Angiographic Features in Symptomatic Macular Polypoidal Choroidal Vasculopathy Over 24 Months
Colin S Tan, MBBS, MMed (Ophth), FRCSEd (Ophth)
Annual Meeting Talks
2019
Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
Carl J Danzig, MD
Updates from the Field
2022

Category: Diabetic Retinopathy

See more